Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Coronary angioplasty

Fluosol-DA, a 20% by weight emulsion, has been Hcensed for use ia coronary angioplasty. As of 1991, this product was available through the U.S. Food and Dmg Administration (FDA) for compassionate use. [Pg.161]

Abciximab Glycoprotein llb/llla antibody Coronary angioplasty... [Pg.603]

Percutaneous coronary intervention (PCI) is one of a host of techniques performed by using a catheter inserted via a major limb artery that aims to relieve nanowing of coronary arteries. For example, percutaneous transluminal coronary angioplasty (PTCA) is the classic PCI that uses a catheter-directed balloon to dilate a stenotic coronary artery, and more recent PCIs include stent implantation, rotational atherectomy, and laser angioplasty. [Pg.938]

PT Pertussis toxin PTCA Percutaneous transluminal coronary angioplasty PTCR Percutaneous transluminal coronary recanalization Pte-H Tetrahydropteridine PUFA Polyunsaturated fatty acid PUMP-1 Punctuated metalloproteinase also known as matrilysin... [Pg.285]

Coronary interventions (coronary bypass, percutaneous transluminal coronary angioplasty, or stents)... [Pg.181]

Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002 162 329-336. [Pg.372]

PTCA Percutaneous transluminal coronary angioplasty Sao2 Arterial oxygen percent saturation... [Pg.1557]

Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vase Biol 2001 21(3) 327-334. [Pg.225]

Cardiac catheterization and coronary angiography are used in patients with suspected CAD to document the presence and severity of disease as well as for prognostic purposes. Interventional catheterization is used for thrombolytic therapy in patients with acute MI and for managing patients with significant CAD to relieve obstruction through percutaneous transluminal coronary angioplasty, atherectomy, laser treatment, or stent placement. [Pg.146]

Perchlorotoluene, 6 327 Perchlorylation, 12 183 Perchloryl fluoride, 18 279 Percolation leaching, 16 153 Percolation processes of filled polymers, 11 303 for wood, 26 358-359 Percolation theory, 20 345 23 63 Percolation transition, 10 16 Percutaneous transluminal coronary angioplasty (PTCA), 3 712 -per- designation, 7 609t PE resins, applications of, 20 206t. See also Polyethylene (PE)... [Pg.681]

Tardif, J., Probucol and multivitamins in the prevention of restenosis after coronary angioplasty, N. Engl. Med., 337,365-372,1997. [Pg.562]

Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996 28 1127-1133. [Pg.202]

Mickelson JK, Lakkis NM, VillarrealLevy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty a mechanism for recurrent disease. J Am Coll Cardiol 1996 28 345-353. [Pg.202]

Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999 34 1512-1521. [Pg.206]

Pepine CJ, Hirshfeld JW, Macdonald RG, et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. Circulation 1990 81 1753-1761. [Pg.206]

Stone GW, Rutherford BD, McConahay DR, et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 1989 18 227-231. [Pg.206]

Pietersma A, Kofllard M, Dewit LEA, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995 91 1320-1325. [Pg.206]

Bittl JA, Chaitman BR, Feit F, Kimball W, Topol EJ. (2001) Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina Final report reanalysis of the bivalirudin angioplasty study. Am Heart J142 952-959. [Pg.154]

The safety and efficacy of bivalirudin have not been established in patients with acute coronary syndromes who are not undergoing percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). [Pg.157]

PTCA percutaneous transluminal coronary angioplasty PTH parathyroid hormone PTT partial thromboplastin time PUD peptic ulcer disease pulm pulmonary PVC premature ventricular contraction... [Pg.449]

The treatment of CAD for the alleviation of angina was evaluated in several trials that ultimately shaped the role of coronary angioplasty. Prior to this, trials such as the Veterans Administration Cooperative Study (VA Study) [13, 14] and the Coronary Artery Surgery Study (CASS) trial [15] established the role of revascularization for the improvement in survival and symptom relief A meta-analysis (Table 5.1) regarding surgical revascularization (CABG) versus... [Pg.71]

Simpson JB, Bairn DS, Robert EW, Harrison DC. A new catheter system for coronary angioplasty. Am J Cardiol 1982 49 1216. [Pg.81]

Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris outcomes for patients with double-vessel versus single—vessel coronary artery disease in a Vererans Affairs cooperative randomized trial. J Am Coll Cardiol 1997 29 1505. [Pg.81]

RITA 2 Trial Participants. Coronary angioplasty versus medical therapy for angina The second Randomized Intervention Treatment of Angina trial. Lancer 1997 350 461. [Pg.82]

RITA Trial Participants. Coronary angioplasty vs. coronary artery bypass surgery the randomized intervention treatment of angina trial. Lancet 1993 341 573. [Pg.82]

Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993 22 1060. [Pg.82]

Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study coronary angioplasty wih stenting versus coronary artery bypass surgery in patients with multiple vessel disease 30-day and one year follow-up results. J Am Coll Cardiol 2001 37 51-58. [Pg.82]

Rodriguez A, Baldi J, Pereira C, et al. Five-year followup of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease. J Am Coll Cardiol 2005 46 583-588. [Pg.82]

O Keefe JH, Jr., Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989 64 1221-1230. [Pg.82]

See other pages where Coronary angioplasty is mentioned: [Pg.177]    [Pg.179]    [Pg.180]    [Pg.181]    [Pg.255]    [Pg.145]    [Pg.186]    [Pg.73]    [Pg.82]    [Pg.149]    [Pg.209]    [Pg.92]    [Pg.153]    [Pg.184]    [Pg.82]    [Pg.316]    [Pg.521]    [Pg.46]    [Pg.70]    [Pg.71]   
See also in sourсe #XX -- [ Pg.357 ]

See also in sourсe #XX -- [ Pg.51 ]



SEARCH



Angioplasty

Angioplasty procedure, percutaneous transluminal coronary

Coronary angioplasty, percutaneous

Percutaneous transluminal coronary angioplasty

Percutaneous transluminal coronary angioplasty complications

Percutaneous transluminal coronary angioplasty restenosis after

Percutaneous transluminal coronary angioplasty sirolimus

Restenosis after coronary angioplasty

Transluminal coronary angioplasty

© 2024 chempedia.info